Max J. Pachl

Dr. Max J. Pachl

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2020 in The Annals of The Royal College of Surgeons of England
Verified
Journal Article
Closed access
MPMax J. Pachl
Max J. Pachl
GAGs Arul
Gs Arul
IJI Jester
I Jester
CBC Bowen
C Bowen
DHD Hobin
D Hobin
BMB Morland
B Morland
Background Congenital mesoblastic nephroma is a rare disease. Treatment is surgical in the first instance. Chemotherapy has traditionally been thought not to have a role. Recent literature suggests...

1 December 2020 in Surgical Oncology
Verified
Journal Article
Closed access
EGElizabeth Gavens
Elizabeth Gavens
GAG. Suren Arul
G. Suren Arul
MPMax J. Pachl
Max J. Pachl

27 May 2023 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
AHAnna Cv Harris
Anna Cv Harris
SCS Choudhury
S Choudhury
MPMax J. Pachl
Max J. Pachl

10 July 2024 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
MPMax J. Pachl
Max J. Pachl
TLTimothy B. Lautz
Timothy B. Lautz
JAJennifer H. Aldrink
Jennifer H. Aldrink
Abdelhafeez AbdelhafeezAbdelhafeez Abdelhafeez
Abdelhafeez Abdelhafeez
SISabine Irtan
Sabine Irtan

1 November 2024 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
RRRebecca Roberts
Rebecca Roberts
MPMax J. Pachl
Max J. Pachl
Introduction: Correctly identifying positive lymph nodes associated with pediatric renal tumors is key to guiding management. Recommended targets for lymph node sampling are commonly missed during tumor nephrectomy, particularly if minimally invasive surgery (MIS) is performed. Indocyanine green (ICG) is used for lymph node mapping in adult oncology with excellent efficacy and safety profile. Materials and Methods: A prospective study was undertaken at a single-quaternary-level pediatric surgery center. All patients undergoing MIS radical or partial nephrectomy for renal tumors 2016-2023 were included. Patients managed from 2020 onwards received intra-parenchymal ICG prior to lymph node sampling. Main Results: Twenty-five patients underwent MIS nephrectomy at mean age 2 years 10 months. Eighteen patients were pre-ICG and 7 received ICG. ICG administration successfully demonstrated fluorescent nodes in all patients. Median number of nodes sampled was three pre-ICG and seven with ICG (P = 0.009). Forty-six nodes were sampled across 7 ICG patients-33 fluorescent, 10 non-fluorescent, and 3 identified histologically. Three nodes overall contained active disease, two pre-ICG and one fluorescent node with ICG. Neither operative time (180 pre-ICG versus 161 minutes ICG, P = 0.7) nor length of stay (72 versus 84 hours, P = 0.3) were significantly affected by ICG administration. There were no adverse events associated with ICG use. Conclusions: ICG is safe and effective at identifying nodes in MIS resection of pediatric renal tumors with the potential to increase the number of nodes sampled. Further research is needed, specifically a randomized control trial with extended follow-up.